Medical Research
(H30)
IRS Verified
DX Registered
990 on File
GRAY FOR GLIOBLASTOMA SOCIETY
Financial strength (30%)
57/100
Reliability (20%)
40/100
Effectiveness (25%)
58/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Gray for Glioblastoma is a 501(c)(3) nonprofit dedicated to raising awareness and funding for Glioblastoma Multiforme (GBM) research while fostering a supportive, hopeful community for patients and caregivers
Financial Overview — FY 2024
$255K
Total Revenue
$248K
Total Expenses
$71K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
61.3%
Fundraising Efficiency
130.7%
Operating Reserve
3.42x
Liability-to-Asset
0.0%
Revenue Diversification
92.5%
Compared with Peers
FY 2024
Compared with 726 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
61.3% | 84.5% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
0.0% | 11.4% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
38.7% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
130.7% | 10.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
3.4 mo | 13.4 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.4% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
92.5% | 93.3% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
21.3% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
42.6% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
2.9% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $255K | $248K | $71K | 61.3% | 0 |
| 2023 | $211K | $174K | $63K | 89.7% | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.